521 related articles for article (PubMed ID: 18574761)
41. The SEIQoL-DW for assessing quality of life in ALS: strengths and limitations.
Felgoise SH; Stewart JL; Bremer BA; Walsh SM; Bromberg MB; Simmons Z
Amyotroph Lateral Scler; 2009; 10(5-6):456-62. PubMed ID: 19922140
[TBL] [Abstract][Full Text] [Related]
42. A comparative study of variables that have an impact on noncancer end-of-life diagnoses.
Dobratz M
Clin Nurs Res; 2004 Nov; 13(4):309-25. PubMed ID: 15448282
[TBL] [Abstract][Full Text] [Related]
43. Quality of life in amyotrophic lateral sclerosis patients and caregivers: Impact of assistive communication from early stages.
Londral A; Pinto A; Pinto S; Azevedo L; De Carvalho M
Muscle Nerve; 2015 Dec; 52(6):933-41. PubMed ID: 25808635
[TBL] [Abstract][Full Text] [Related]
44. ALSFRS and appel ALS scores: discordance with disease progression.
Voustianiouk A; Seidel G; Panchal J; Sivak M; Czaplinski A; Yen A; Appel SH; Lange DJ
Muscle Nerve; 2008 May; 37(5):668-72. PubMed ID: 18288708
[TBL] [Abstract][Full Text] [Related]
45. Amyotrophic lateral sclerosis and assisted ventilation: how patients decide.
Lemoignan J; Ells C
Palliat Support Care; 2010 Jun; 8(2):207-13. PubMed ID: 20557668
[TBL] [Abstract][Full Text] [Related]
46. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial.
Kaufmann P; Levy G; Montes J; Buchsbaum R; Barsdorf AI; Battista V; Arbing R; Gordon PH; Mitsumoto H; Levin B; Thompson JL;
Amyotroph Lateral Scler; 2007 Feb; 8(1):42-6. PubMed ID: 17364435
[TBL] [Abstract][Full Text] [Related]
47. Coping strategies as related to medical and demographic data in amyotrophic lateral sclerosis.
Montel S; Albertini L; Spitz E
Acta Neurol Scand; 2012 Feb; 125(2):136-41. PubMed ID: 21470190
[TBL] [Abstract][Full Text] [Related]
48. Coping strategies in relation to quality of life in amyotrophic lateral sclerosis.
Montel S; Albertini L; Spitz E
Muscle Nerve; 2012 Jan; 45(1):131-4. PubMed ID: 22190320
[TBL] [Abstract][Full Text] [Related]
49. Trends and determinants of end-of-life practices in ALS in the Netherlands.
Maessen M; Veldink JH; Onwuteaka-Philipsen BD; de Vries JM; Wokke JH; van der Wal G; van den Berg LH
Neurology; 2009 Sep; 73(12):954-61. PubMed ID: 19770471
[TBL] [Abstract][Full Text] [Related]
50. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40.
Jenkinson C; Fitzpatrick R; Brennan C; Swash M
Amyotroph Lateral Scler Other Motor Neuron Disord; 1999 Dec; 1(1):33-40. PubMed ID: 12365067
[TBL] [Abstract][Full Text] [Related]
51. Cross-cultural adaptation and validation of the 'Multiple Sclerosis Quality of Life Instrument' in Hungarian.
Füvesi J; Bencsik K; Benedek K; Mátyás K; Mészáros E; Rajda C; Losonczi E; Fricska-Nagy Z; Vécsei L
Mult Scler; 2008 Apr; 14(3):391-8. PubMed ID: 18208896
[TBL] [Abstract][Full Text] [Related]
52. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis.
Kübler A; Winter S; Ludolph AC; Hautzinger M; Birbaumer N
Neurorehabil Neural Repair; 2005 Sep; 19(3):182-93. PubMed ID: 16093409
[TBL] [Abstract][Full Text] [Related]
53. Validity of the ALS-Depression-Inventory (ADI-12)--a new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis.
Hammer EM; Häcker S; Hautzinger M; Meyer TD; Kübler A
J Affect Disord; 2008 Jul; 109(1-2):213-9. PubMed ID: 18262283
[TBL] [Abstract][Full Text] [Related]
54. Oropharyngeal dysphagia in amyotrophic lateral sclerosis alters quality of life.
Paris G; Martinaud O; Petit A; Cuvelier A; Hannequin D; Roppeneck P; Verin E
J Oral Rehabil; 2013 Mar; 40(3):199-204. PubMed ID: 23278936
[TBL] [Abstract][Full Text] [Related]
55. Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40).
Jenkinson C; Peto V; Jones G; Fitzpatrick R
Clin Rehabil; 2003 Jul; 17(4):380-5. PubMed ID: 12785246
[TBL] [Abstract][Full Text] [Related]
56. [Reliability and factorial structure of a rating scale for amyotrophic lateral sclerosis].
Oda E; Ohashi Y; Tashiro K; Mizuno Y; Kowa H; Yanagisawa N
No To Shinkei; 1996 Nov; 48(11):999-1007. PubMed ID: 8951891
[TBL] [Abstract][Full Text] [Related]
57. [Psychological and psychopathological assessment of the patient with amyotrophic lateral sclerosis].
Havet V
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S164-4S172. PubMed ID: 17128106
[TBL] [Abstract][Full Text] [Related]
58. [Quality of life of patients with amyotrophic lateral sclerosis].
Leirvik A; Liverød M; Holmøy T
Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2520-2. PubMed ID: 17028632
[TBL] [Abstract][Full Text] [Related]
59. [The meeting between patients and professionals who treat them. Qualitative interview of patients with amyotrophic lateral sclerosis and their closest relatives].
Timm HU
Ugeskr Laeger; 1996 Mar; 158(13):1812-7. PubMed ID: 8650755
[TBL] [Abstract][Full Text] [Related]
60. Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time.
Olsson AG; Markhede I; Strang S; Persson LI
Acta Neurol Scand; 2010 Apr; 121(4):244-50. PubMed ID: 20028340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
